LifeWallet Acquires Assignment of Additional MSP Claims with an Overall Paid Amount Exceeding $10.6 billion Comprised of Over 450,000 Medicare Members and Announces it Secured a Waiver of Acceleration on a Second Loan Agreement in the Event of a Negative G
October 02 2024 - 8:22AM
MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW)
(“LifeWallet” or “the Company”), as previously announced
on August 2, 2024, today LifeWallet entered into a definitive
agreement with Hazel Partners Holdings LLC consistent with the
letter agreement.1 LifeWallet acquired the recovery rights to
claims as per its assignment of additional Medicare Secondary Payer
claims consisting of more than 450,000 Medicare members, as
documented by health insurance plans, with an estimated total
claims paid amount exceeding $10.6 billion.2
This latest assignment of Medicare Secondary Payer claims
exemplifies LifeWallet’s continued progress in acquiring additional
healthcare claims, paving the way for the discovery and potential
recovery of improperly paid claims on the part of Medicare Payers.
Because of LifeWallet’s existing settlements with insurance
companies, any claims pertaining to insurance companies that have
already been settled, would be processed under the terms of the
settlement without having to resort to costly and time-consuming
litigation.
In addition to providing historic claims payment reconciliation,
these claims will be onboarded onto the LifeWallet Palantir
clearinghouse system, a sophisticated data analytics system created
through an exclusive healthcare partnership with Palantir
Technologies (NYSE: PLTR). This system utilizes the Palantir
Foundry platform through the development of new technological tools
and machine learning. It captures and manages healthcare data
effectively, enhancing the identification of improper payments.
This further enhances LifeWallet’s Chase to Pay model, utilizing
its extensive legal infrastructure to enforce Primary Payer
obligations through years of federal and state litigation to the
extent the health insurance plans are signed. The Company continues
to create reimbursement recovery solutions for health insurance
plans and healthcare providers, discovering Medicare liens owed to
them, capturing instances where another payer should be paying for
medical bills, saving the health insurance plans money by not
having to pay claims they are not responsible for, and recovering
conditional payments from responsible primary payers, such as
property and casualty insurers.
LifeWallet’s CIO, Christopher Miranda, said of today’s
announcement, “This builds upon the Company’s more than ten-year
commitment to revolutionize the fragmented healthcare reimbursement
system with data-driven solutions, resulting in improved outcomes
for healthcare payers, providers, leading to improved patient
care.”
Waiver from Hazel Partners Holdings, LLC and Virage
Capital Partners
LifeWallet also announces the waiver of a payment acceleration
clause pursuant to a material credit agreement. Hazel Partners
Holdings, LLC (“Hazel”) agreed to waive a provision of the Second
Amended and Restated Credit Agreement, as amended, that otherwise
would have accelerated the payment of amounts due in the event that
the Company receives a negative going concern opinion from its
auditors. This waiver only applies in the event that the Company
receives a negative going concern opinion for the fiscal year
ending December 31, 2024. This is in addition to a previous waiver
of acceleration also granted by its largest creditor, Virage
Capital Partners (“Virage”). On September 6, 2024, Virage agreed to
waive a provision of the Company’s Master Transaction Agreement
that would accelerate the payment of amounts due to Virage in the
event the Company receives a negative going concern opinion from
its auditors for the year ending December 31, 2024. The company
continues to work on expense reductions and efforts to restructure
existing debt while monitoring its deployment of cash and
increasing its liquidity inflows.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of the federal securities laws. Forward-looking
statements may generally be identified by the use of words such as
“anticipate,” “believe,” “expect,” “intend,” “plan" and “will” or,
in each case, their negative, or other variations or comparable
terminology. These forward-looking statements include all matters
that are not historical facts, including for example statements
regarding potential future settlements. By their nature,
forward-looking statements involve risks and uncertainties because
they relate to events and depend on circumstances that may or may
not occur in the future. As a result, these statements are not
guarantees of future performance or results and actual events may
differ materially from those expressed in or suggested by the
forward-looking statements. Any forward-looking statement made by
the Company herein speaks only as of the date made. New risks and
uncertainties come up from time to time, and it is impossible for
the Company to predict or identify all such events or how they may
affect it. the Company has no obligation, and does not intend, to
update any forward-looking statements after the date hereof, except
as required by federal securities laws. Factors that could cause
these differences include, but are not limited to, the Company’s
ability to capitalize on its assignment agreements and recover
monies that were paid by the assignors; the inherent uncertainty
surrounding settlement negotiations and/or litigation, including
with respect to both the amount and timing of any such results; the
success of the Company's scheduled settlement mediations; the
validity of the assignments of claims to the Company; negative
publicity concerning healthcare data analytics and payment
accuracy; and those other factors included in the Company’s Annual
Report on Form 10-K, Quarterly Reports on Form 10-Q and other
reports filed by it with the SEC. These statements constitute the
Company’s cautionary statements under the Private Securities
Litigation Reform Act of 1995.
About LifeWallet
Founded in 2014 as MSP Recovery, LifeWallet has become a
Medicare, Medicaid, commercial, and secondary payer reimbursement
recovery leader, disrupting the antiquated healthcare reimbursement
system with data-driven solutions to secure recoveries from
responsible parties. LifeWallet provides comprehensive solutions
for multiple industries including healthcare, legal, and sports
NIL. For more information, visit: LIFEWALLET.COM.
CONTACTS
MediaICR,
Inc.MSP@icrinc.com
InvestorsInvestors@LifeWallet.com
______________________________
1 On August 2, 2024, Subrogation Holdings, LLC, a wholly owned
subsidiary of MSP Recovery, Inc. d/b/a LifeWallet (the “Company”)
entered into a letter agreement (the “HPH Letter Agreement”)
whereby the parties have set out the terms to amend the Second
Amended and Restated Credit Agreement with Hazel Partners Holdings
LLC (the “Credit Agreement”), to: (i) extend the period for the
Company to draw up to $14 million for working capital, accessible
in eight tranches of $1.75 million, that can be drawn at least one
month apart, until September 2025; and (ii) provide for a $2.0
million loan to be funded by August 31, 2024 for the purpose of
acquiring additional Claims (the “New Claims”) that will further
collateralize the Working Capital Credit Facility (collectively,
(i) and (ii) the “Operational Collection Floor”). The parties have
agreed that such amendment to the Credit Agreement shall be agreed
and entered into at a later date.
2 “Paid Amount” (a/k/a Medicare Paid Rate or wholesale price)
means the amount paid to the provider from the health plan or
insurer. This amount varies based on the party making payment. For
example, Medicare typically pays a lower fee for service rate than
commercial insurers. The Paid Amount is derived from the Claims
data we receive from our Assignors. In the limited instances where
the data received lacks a paid value, our team calculates the Paid
Amount with a formula. The formula used provides rates for
outpatient services and is derived from the customary rate at the
95th percentile as it appears from standard industry commercial
rates or, where that data is unavailable, the Billed Amount if
present in the data. These amounts are then adjusted to account for
the customary Medicare adjustment to arrive at the calculated Paid
Amount. Management believes that this formula provides a
conservative estimate for the Medicare paid amount rate, based on
industry studies which show the range of differences between
private insurers and Medicare rates for outpatient services. We
periodically update this formula to enhance the calculated paid
amount where that information is not provided in the data received
from our Assignors. Management believes this measure provides a
useful baseline for potential recoveries, but it is not a measure
of the total amount that may be recovered in respect of potentially
recoverable Claims, which in turn may be influenced by any
applicable potential statutory recoveries such as double damages or
fines. Where we have to extrapolate a Paid Amount to establish
damages, the calculated amount may be contested by opposing
parties. The figures pertaining to Medicare Member Lives as well as
the paid amount were tabulated based on the data provided by health
care plans; these figures may be subject to adjustment upon further
investigation of the paid amounts reflected by the health
plans.
Palantir Technologies (NYSE:PLTR)
Historical Stock Chart
From Oct 2024 to Nov 2024
Palantir Technologies (NYSE:PLTR)
Historical Stock Chart
From Nov 2023 to Nov 2024